[53] The trials were conducted at 673 sites in 24 countries, including Argentina, Australia, Brazil, Canada, India, Israel, Japan, Mexico, Russian Federation, South Korea, Taiwan, European Union, and the United States (including Puerto Rico)
Additionally, the study looked at cardiovascular outcomes as a pre-specified secondary analysis which included a four-point composite endpoint of cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina
The choice of supplements has expanded over time and it is now possible to obtain highly-absorbable forms such as S-acetyl glutathione
Interest is up, too
Shown to support up to 22% weight loss in clinical studies, higher than Semaglutide Not recommended for individuals with a history of medullary thyroid cancer or pancreatitis
Many patients find that side effects become less noticeable after the first several weeks